Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Cellectar Biosciences Inc (NASDAQ: CLRB) closed at $0.30 in the last session, down -5.37% from day before closing price of $0.32. In other words, the price has decreased by -$5.37 from its previous closing price. On the day, 12.92 million shares were traded. CLRB stock price reached its highest trading level at $0.3196 during the session, while it also had its lowest trading level at $0.278.
Ratios:
We take a closer look at CLRB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.77 and its Current Ratio is at 1.77. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 10 ’25 when Longcor Jarrod bought 30,000 shares for $0.28 per share. The transaction valued at 8,400 led to the insider holds 83,141 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLRB now has a Market Capitalization of 13805538 and an Enterprise Value of -4164165.
Stock Price History:
The Beta on a monthly basis for CLRB is 0.66, which has changed by -0.9137931 over the last 52 weeks, in comparison to a change of 0.07903516 over the same period for the S&P500. Over the past 52 weeks, CLRB has reached a high of $4.17, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is 4.11%, while the 200-Day Moving Average is calculated to be -81.54%.
Shares Statistics:
According to the various share statistics, CLRB traded on average about 2.04M shares per day over the past 3-months and 1913700 shares per day over the past 10 days. A total of 46.08M shares are outstanding, with a floating share count of 45.31M. Insiders hold about 1.67% of the company’s shares, while institutions hold 11.18% stake in the company. Shares short for CLRB as of 1740700800 were 1967439 with a Short Ratio of 0.97, compared to 1738281600 on 2355367. Therefore, it implies a Short% of Shares Outstanding of 1967439 and a Short% of Float of 4.7.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
A detailed examination of Cellectar Biosciences Inc (CLRB) is currently in progress, with 3.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.15 and low estimates of -$0.15.
Analysts are recommending an EPS of between -$0.63 and -$0.65 for the fiscal current year, implying an average EPS of -$0.64. EPS for the following year is -$0.85, with 4.0 analysts recommending between -$0.6 and -$1.31.
